Economy News

Patanjali’s Coronil runs into controversy over claims of certification

Coronil, a medicine developed by yoga guru Ramdev that claims to boost immunity against COVID-19 invited trouble over claims of certification.

Further, WHO has clarified in a tweet that it has not reviewed or certified any traditional medicine to treat or prevent COVID-19.

Patanjali stated during the launch event on Friday that Coronil has received the Certificate of Pharmaceutical Product (CoPP).

Moreover, Rakesh Mittal, one of the top executives at Patanjali Ayurved reiterated the claim that WHO has recognized Coronil.

Patanjali Ayurved managing director Acharya Balkrishna later clarified that he said was “to avoid confusion”.

He further added that WHO did not approve or disapprove any drugs.

WHO aims to work for building a better, healthier future for people all over the world.

It also provides benchmarks for certifications but does not certify or approve the medicine itself.

The GMP guidelines provide a set of quality control benchmarks to be adhered to for consistently producing medicines.

Patanjali Ayurved had earlier claimed that Coronil could provide strong protection against the coronavirus back in July 2020.

This was however long before vaccines were yet to reach final trails with lockdown restrictions strictly imposed.

In an earlier statement, Patanjali had confirmed that Coronil has the potential to benefit 158 countries.

The company released a research paper by Haridwar-based Patanjali Research Institute to support its claims about the ayurvedic medicine.

Union Health Minister Harsh Vardhan and Transport Minister Nitin Gadkari were also present among others at the launch event.

Check all the recent news updates and share market updates


Get 90% Discount on Brokerage Now! Open Demat Account